Clinical and Experimental Pharmacology and Physiology

SJR Rank #9,337H-index: 121SJR: 0.630Best quartile: Q2APC: US$4,150
Journal website: aims, scope and author guidelines
Publisher

Wiley-Blackwell Publishing Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • PharmacologyQ2
  • PhysiologyQ3
  • Physiology (medical)Q3

Areas: Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Nitric Oxide and Endothelin EffectsReceptor Mechanisms and SignalingRenin-Angiotensin System StudiesHeart Rate Variability and Autonomic ControlHormonal Regulation and HypertensionIon channel regulation and functionNeuropeptides and Animal PhysiologyCardiac electrophysiology and arrhythmiasNeuroscience and Neuropharmacology ResearchEicosanoids and Hypertension Pharmacology

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs075150225300

Documents per Year

2022202503570105140

Detailed Information

ISSN

1440-1681, 0305-1870

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

2.72

References per Document

39.91

Coverage

1974-2026

Scope

Clinical and Experimental Pharmacology and Physiology is an international journal founded in 1974 by Mike Rand, Austin Doyle, John Coghlan and Paul Korner. Our focus is new frontiers in physiology and pharmacology, emphasizing the translation of basic research to clinical practice. We publish original articles, invited reviews and our exciting, cutting-edge Frontiers-in-Research series’.

Metrics from SCImago Journal Rank 2025. View on SCImago